Results 81 to 90 of about 15,396 (178)

Duloxetine Status [PDF]

Pain Medicine, 2007
openaire   +2 more sources

Efficacy of Duloxetine for Postspine Surgery Pain: A Systematic Review and Meta‐Analysis

Brain and Behavior
Background Duloxetine, a serotonin and norepinephrine reuptake inhibitor (SNRI), is used to treat various health conditions, including major depressive disorder, generalized anxiety disorder, fibromyalgia, and off‐label for chemotherapy‐induced pain.
Abdulsalam Mohammed Aleid, Faisal Alshehri, Naif Alasiri, Fatimah Alhomoud, Shouq Alsaegh, Mohammed Alrasheed, Salem Aljaddua, Ali Alasiri, Asma Boukhari, Abdulmonem Ali Alhussain, Bipin Chaurasia, Saud Nayef Aldanyowi   +11 more
doaj   +1 more source

Clinical meaningfulness of duloxetine's effect in Chinese patients with chronic pain due to osteoarthritis: post hoc analyses of a phase 3 randomized trial

Open Access Rheumatology: Research and Reviews, 2019
Li Yue,1 Sheng Luo,2 Yiwen Wang,1 Chia-Ning Wang,1 Héctor José Dueñas,3 Vladimir Skljarevski4 1Lilly Suzhou Pharmaceutical Co. Ltd. Shanghai Branch, Shanghai, PR China; 2Department of Pain Treatment, Beijing Hospital of the Ministry ...
Yue L, Luo S, Wang Y, Wang CN, Dueñas HJ, Skljarevski V   +5 more
doaj  

Postoperative duloxetine administration did not significantly modify overall pain trajectories following high tibial osteotomy: An open-label randomized controlled trial

Journal of Orthopaedic Surgery
Background Duloxetine is a potent analgesic that reduces pain associated with knee osteoarthritis. This study aimed to evaluate the analgesic effects of regular postoperative duloxetine after high tibial osteotomy (HTO) and its influence on knee function,
Masaya Sengoku, Hiroyasu Ogawa, Yutaka Nakamura, Tetsuya Shimokawa, Kazuichiro Ohnishi, Haruhiko Akiyama   +5 more
doaj   +1 more source

Assessment of direct analgesic effect of duloxetine for chronic low back pain: post hoc path analysis of double-blind, placebo-controlled studies

Journal of Pain Research, 2017
Hiroyuki Enomoto,1 Shinji Fujikoshi,2 Jumpei Funai,3 Nao Sasaki,4 Michael H Ossipov,5 Toshinaga Tsuji,6 Levent Alev,7 Takahiro Ushida8 1Medical Science, Eli Lilly Japan K.K., Tokyo, 2Statistical Science, 3Science Communications, 4Medical Science, Eli ...
Enomoto H, Fujikoshi S, Funai J, Sasaki N, Ossipov MH, Tsuji T, Alev L, Ushida T   +7 more
doaj  

Observational study of upper gastrointestinal tract bleeding events in patients taking duloxetine and nonsteroidal anti-inflammatory drugs: a case-control analysis

Drug, Healthcare and Patient Safety, 2014
Hu Li, Yingkai Cheng, Jonna Ahl, Vladimir SkljarevskiNeurosciences, Eli Lilly and Company, Indianapolis, IN, USAPurpose: To determine whether the concomitant use of duloxetine with prescription nonsteroidal anti-inflammatory drugs (NSAIDs) or aspirin was
Li H, Cheng Y, Ahl J, Skljarevski V
doaj  

An observational study of duloxetine versus SSRI monotherapy for the treatment of painful physical symptoms in Japanese patients with major depressive disorder: primary analysis

Neuropsychiatric Disease and Treatment, 2017
Atsushi Kuga,1 Toshinaga Tsuji,2 Shinji Hayashi,2 Mako Matsubara,3 Shinji Fujikoshi,4 Hirofumi Tokuoka,1 Aki Yoshikawa,5 Rodrigo Escobar,6 Kazuhide Tanaka,7 Takaharu Azekawa8 1Bio Medicine, Medicines Development Unit Japan, Eli Lilly Japan K.K., Kobe ...
Kuga A, Tsuji T, Hayashi S, Matsubara M, Fujikoshi S, Tokuoka H, Yoshikawa A, Escobar R, Tanaka K, Azekawa T   +9 more
doaj  

Continuation treatment of major depressive disorder: is there a case for duloxetine?

Drug Design, Development and Therapy, 2010
Trevor R Norman, James S OlverDepartment of Psychiatry, University of Melbourne, Austin Hospital, Heidelberg, Victoria, AustraliaAbstract: Duloxetine is a serotonin–noradrenaline reuptake inhibitor with established efficacy for the ...
Trevor R Norman, James S Olver
doaj  

RETRACTED: Abdi et al. Duloxetine, an SNRI, Targets pSTAT3 Signaling: <i>In</i>-Silico, RNA-Seq and <i>In</i>-Vitro Evidence for a Pleiotropic Mechanism of Pain Relief. <i>Int. J. Mol. Sci.</i> 2025, <i>26</i>, 10432. [PDF]

Int J Mol Sci
Abdi SAH, Azhar G, Zhang X, Wei JY.
europepmc   +1 more source

Neurological Phenotype and MRI Severity as Predictors of Duloxetine Response in Lumbar Spinal Stenosis: A Retrospective Cohort Study. [PDF]

J Clin Med
Honjoh K, Kubota A, Watanabe S, Kamitani M, Watanabe Y, Nakajima H.   +5 more
europepmc   +1 more source